A Contract Development and Manufacturing Organization (CDMO) providing fully integrated drug discovery, process development, analytical and cGMP manufacturing services across the drug development lifecycle.
Open prospective conversations with pharma and biotech companies in the North Carolina region.
Braket ran a tiered ABM program to open conversations with pharma and biotech companies across the US and Canada, targeting North Carolina specifically.
Engaging complex buying committees across disparate CDMO needs in a highly regulated industry.
Generic marketing failing to address specific drug pipelines and therapeutic areas.
Identifying active buyers and capitalizing on massive industry trade shows.
Optimizing for superficial lead volume instead of actual meetings and pipeline progression.